Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonore Unger

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
The Journal of Clinical Investigation|December 16, 2014
Defective removal of ribonucleotides from DNA promotes systemic autoimmunityClaudia Günther, Barbara Kind, Martin A M Reijns, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
The Journal of Clinical Investigation|December 16, 2014
Defective removal of ribonucleotides from DNA promotes systemic autoimmunityClaudia Günther, Barbara Kind, Martin A M Reijns, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 2